A Phase II Trial of the Proteasome Inhibitor Bortezomib in Patients With Advanced Biliary Tract Cancers

Clinical Colorectal Cancer - United States
doi 10.1016/j.clcc.2013.12.005
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Binimetinib Plus Gemcitabine and Cisplatin Phase I/Ii Trial in Patients With Advanced Biliary Cancers

Clinical Cancer Research
Cancer ResearchOncology
2019English

A Phase I Trial Investigating Pulsatile Erlotinib in Combination With Gemcitabine and Oxaliplatin in Advanced Biliary Tract Cancers

Investigational New Drugs
OncologyPharmacology
2016English

A Phase II Trial of Fixed-Dose Rate Gemcitabine Plus Capecitabine in Metastatic/Advanced Biliary Tract Cancer Patients

Oncology
MedicineCancer ResearchOncology
2012English

Phase I Clinical Trial of Multiple-Peptide Vaccination for Patients With Advanced Biliary Tract Cancer

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2014English

Phase I/Ii Trial of Imatinib and Bevacizumab in Patients With Advanced Melanoma and Other Advanced Cancers

Oncologist
Cancer ResearchMedicineOncology
2015English

A Phase IB Trial of 24-Hour Intravenous PX-12, a Thioredoxin-1 Inhibitor, in Patients With Advanced Gastrointestinal Cancers

Investigational New Drugs
OncologyPharmacology
2012English

A Phase II Trial of Valproic Acid in Patients With Advanced, Radioiodine-Resistant Thyroid Cancers of Follicular Cell Origin

Clinical Endocrinology
EndocrinologyMetabolismDiabetes
2016English

The Epothilone B Analogue Ixabepilone in Patients With Advanced Hepatobiliary Cancers: A Trial of the University of Chicago Phase II Consortium

Investigational New Drugs
OncologyPharmacology
2009English

A Phase I Trial of Bortezomib and Sorafenib in Advanced Malignant Melanoma

Oncologist
Cancer ResearchMedicineOncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy